Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 1
2011 3
2012 3
2013 3
2014 2
2016 2
2017 5
2018 1
2019 1
2020 2
2021 3
2022 6
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Co-morbidities in established rheumatoid arthritis.
Gullick NJ, Scott DL. Gullick NJ, et al. Best Pract Res Clin Rheumatol. 2011 Aug;25(4):469-83. doi: 10.1016/j.berh.2011.10.009. Best Pract Res Clin Rheumatol. 2011. PMID: 22137918 Review.
Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
Campanholo CB, Maharaj AB, Corp N, Bell S, Costa L, de Vlam K, Gullick NJ, Khraishi M, Kishimoto M, Palmou-Fontana N, Reddy S, Scarpa R, Vega L, Duarte GV, Zisman D, van der Windt DA, Duruoz MT, Ogdie A. Campanholo CB, et al. Among authors: gullick nj. J Rheumatol. 2023 Mar;50(3):426-432. doi: 10.3899/jrheum.220310. Epub 2022 Nov 1. J Rheumatol. 2023. PMID: 36319003 Free article.
Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England.
Quick V, Abusalameh M, Ahmed S, Alkoky H, Bukhari M, Carter S, Coath FL, Davidson B, Doddamani P, Dubey S, Ducker G, Griffiths B, Gullick N, Heaney J, Holloway A, Htut EEP, Hughes M, Irvine H, Kinder A, Kurshid A, Lim J, Ludwig DR, Malik M, Mercer L, Mulhearn B, Nair JR, Patel R, Robson J, Saha P, Tansley S; TOC STOP 2022 Investigators; Mackie SL. Quick V, et al. Among authors: gullick n. Rheumatology (Oxford). 2023 Nov 11:kead604. doi: 10.1093/rheumatology/kead604. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37952183
Patient perceptions of co-morbidities in inflammatory arthritis.
Koduri GM, Gullick NJ, Hayes F, Dubey S, Mukhtyar C. Koduri GM, et al. Among authors: gullick nj. Rheumatol Adv Pract. 2021 Jan 11;5(1):rkaa076. doi: 10.1093/rap/rkaa076. eCollection 2021. Rheumatol Adv Pract. 2021. PMID: 33615128 Free PMC article.
The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope.
Mercer L, Abhishek A, Kavirayani A, Ahmed A, Davidson A, Foulkes A, Jones C, Nash C, Rose-Parfitt E, Dhillon E, Zabate G, Twohig H, De Vere H, Scott J, Reynolds J, Holmes J, Hartley K, Warrier K, Nowak K, Parsons K, Bechman K, Bray L, Adikari M, Wood N, Faithfull N, Gullick N, Saha P, Heaton R, Deepak S, Hider S, Khalid S, Said SS, Ryan S, Kyle S, Raghuvanshi S, Tan SY, Shivamurthy V, Galloway J. Mercer L, et al. Among authors: gullick n. Rheumatol Adv Pract. 2024 Jul 12;8(3):rkae077. doi: 10.1093/rap/rkae077. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 39006537 Free PMC article. Review.
Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial.
Worth C, Al-Mossawi MH, Macdonald J, Fisher BA, Chan A, Sengupta R, Packham J, Gaffney K, Gullick N, Cook JA, Corn TH, Teh J, Machado PM, Taylor PC, Bowness P. Worth C, et al. Among authors: gullick n. Lancet Rheumatol. 2024 Aug;6(8):e537-e545. doi: 10.1016/S2665-9913(24)00099-7. Epub 2024 Jun 25. Lancet Rheumatol. 2024. PMID: 38942047 Free article. Clinical Trial.
The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs.
Tucker L, Allen A, Chandler D, Ciurtin C, Dick A, Foulkes A, Gullick N, Helliwell P, Jadon D, Jones G, Kyle S, Madhok V, McHugh N, Parkinson A, Raine T, Siebert S, Smith C, Tillett W, Coates LC. Tucker L, et al. Among authors: gullick n. Rheumatology (Oxford). 2022 Aug 30;61(9):e255-e266. doi: 10.1093/rheumatology/keac295. Rheumatology (Oxford). 2022. PMID: 35640657 No abstract available.
40 results